Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Phase II evaluation of thalidomide in patients with metastatic breast cancer. J Clin Oncol. 2000 Jul; 18(14):2710-7.
View in:
PubMed
subject areas
Adult
Aged
Angiogenesis Inhibitors
Breast Neoplasms
Drug Administration Schedule
Endothelial Growth Factors
Female
Fibroblast Growth Factor 2
Growth Substances
Humans
Lymphokines
Matrix Metalloproteinases
Middle Aged
Neoplasm Metastasis
Prospective Studies
Thalidomide
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
authors with profiles
Gini Fleming